SG Americas Securities’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

SG Americas Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-350,000	Closed	-$858K	–	3855
2020 Q1	$858K	Buy	350,000 +290,000	+483%	+$2.97M	0.01%	1403
2019 Q4	$152K	Hold	60,000	–	–	﹤0.01%	2682
2019 Q3	$330K	Sell	60,000 -254,000	-81%	-$1.95M	﹤0.01%	2104
2019 Q2	$2.37M	Sell	314,000 -75,000	-19%	-$904K	0.02%	910
2019 Q1	$859K	Sell	389,000 -971,000	-71%	-$17.1M	0.01%	1402
2018 Q4	$4.53M	Buy	1,360,000 +140,000	+11%	+$2.87M	0.04%	427
2018 Q3	$1.79M	Buy	1,220,000 +915,000	+300%	+$21.2M	0.01%	1248
2018 Q2	$109K	Sell	305,000 -235,000	-44%	-$4.79M	﹤0.01%	3015
2018 Q1	$1.39M	Sell	540,000 -177,400	-25%	-$3.46M	0.01%	1083
2017 Q4	$1.53M	Buy	717,400 +648,500	+941%	+$9.76M	0.01%	1062
2017 Q3	$517K	Sell	68,900 -56,100	-45%	-$1.26M	﹤0.01%	1820
2017 Q2	$81K	Hold	125,000	–	–	﹤0.01%	2963
2017 Q1	$199K	Buy	125,000 +21,000	+20%	+$717K	﹤0.01%	2439
2016 Q4	$920K	Sell	104,000 -150,000	-59%	-$5.99M	0.01%	1351
2016 Q3	$1.62M	Buy	254,000 +65,000	+34%	+$3.39M	0.02%	860
2016 Q2	$439K	Buy	189,000 +139,000	+278%	+$7.4M	﹤0.01%	1767
2016 Q1	$98K	Buy	+50,000	New	+$2.93M	﹤0.01%	2633
2014 Q1	–	Sell	-100,000	Closed	-$16K	–	2776
2013 Q4	$16K	Hold	100,000	–	–	﹤0.01%	2528
2013 Q3	$173K	Hold	100,000	–	–	﹤0.01%	2280
2013 Q2	$183K	Buy	+100,000	New	+$3.89M	﹤0.01%	1780

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

SG Americas Securities's TEVA Position: Q2 2026 in Review

SG Americas Securities increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 64% in Q2 2026, buying an estimated $16.7M and bringing the position to 1,282,256 shares worth $43.4M. The position accounts for 0.02% of the portfolio, ranked #382.

SG Americas Securities first reported a position in TEVA in Q2 2013 and has held it in 51 quarters since. The position peaked at $53.7M in Q2 2014. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

SG Americas Securities held 1,282,256 shares of Teva Pharmaceutical Industries Limited worth $43.4M as of Q2 2026.
SG Americas Securities bought 501,738 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $16.7M.
Teva Pharmaceutical Industries Limited made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #382 holding.
SG Americas Securities first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 51 quarters since.
SG Americas Securities's Teva Pharmaceutical Industries Limited position peaked at $53.7M in Q2 2014.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.